Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E, particularly in the form of gamma-tocopherol, has been studied for its potential cardiovascular benefits, though the strength of the evidence is limited. Early observational studies suggested that higher intakes of Vitamin E might be associated with a reduced risk of coronary heart disease, possibly due to its antioxidant properties that could prevent oxidative modification of LDL cholesterol, a key step in atherosclerosis development. However, most of these studies did not specify the tocopherol form (alpha, gamma, etc.), and gamma-tocopherol is less commonly used in supplements compared to alpha-tocopherol.

Randomized controlled trials (RCTs) and meta-analyses have generally focused on alpha-tocopherol and have failed to consistently show a significant benefit of Vitamin E supplementation for heart disease prevention or treatment. Some studies have even suggested potential harm with high-dose Vitamin E supplementation. For gamma-tocopherol, clinical evidence is even more sparse; a few small studies have explored its effects on inflammation and endothelial function, but there is insufficient data to draw firm conclusions regarding its use for cardiac weakness or heart failure.

Overall, while the antioxidant hypothesis provides a rationale for studying Vitamin E in cardiovascular health, current scientific evidence does not robustly support the use of Vitamin E—especially gamma-tocopherol—for the treatment of heart weakness. Major clinical guidelines do not recommend Vitamin E supplementation for this purpose.

More about Vitamin E (gamma unspecified)
More about Heart (weakness)

Other ingredients used for Heart (weakness)

Other health conditions supported by Vitamin E (gamma unspecified)

Products containing Vitamin E (gamma unspecified)